Okra (Abelmoschus Esculentus) as a Potential Dietary Medicine with Nutraceutical Importance for Sustainable Health Applications
- PMID: 33525745
- PMCID: PMC7865958
- DOI: 10.3390/molecules26030696
Okra (Abelmoschus Esculentus) as a Potential Dietary Medicine with Nutraceutical Importance for Sustainable Health Applications
Abstract
Recently, there has been a paradigm shift from conventional therapies to relatively safer phytotherapies. This divergence is crucial for the management of various chronic diseases. Okra (Abelmoschus esculentus L.) is a popular vegetable crop with good nutritional significance, along with certain therapeutic values, which makes it a potential candidate in the use of a variety of nutraceuticals. Different parts of the okra fruit (mucilage, seed, and pods) contain certain important bioactive components, which confer its medicinal properties. The phytochemicals of okra have been studied for their potential therapeutic activities on various chronic diseases, such as type-2 diabetes, cardiovascular, and digestive diseases, as well as the antifatigue effect, liver detoxification, antibacterial, and chemo-preventive activities. Moreover, okra mucilage has been widely used in medicinal applications such as a plasma replacement or blood volume expanders. Overall, okra is considered to be an easily available, low-cost vegetable crop with various nutritional values and potential health benefits. Despite several reports about its therapeutic benefits and potential nutraceutical significance, there is a dearth of research on the pharmacokinetics and bioavailability of okra, which has hampered its widespread use in the nutraceutical industry. This review summarizes the available literature on the bioactive composition of okra and its potential nutraceutical significance. It will also provide a platform for further research on the pharmacokinetics and bioavailability of okra for its possible commercial production as a therapeutic agent against various chronic diseases.
Keywords: antidiabetic; cardioprotective; functional foods; nutraceuticals; okra; phytotherapy.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
References
-
- Jain N., Jain R., Jain V., Jain S. A review on: Abelmoschus esculentus. Pharmacia. 2012;1:84–89.
-
- Lamont W.J. Okra—A versatile vegetable crop. Hort Technol. 1999;9:179–184. doi: 10.21273/HORTTECH.9.2.179. - DOI
-
- Tindall H.D. Vegetables in the Tropics. Macmillan Publishers Limited; London, UK: 1983. - DOI
-
- Dhaliwal M.S. Okra (Abelmoschus esculentus) L. (Moench) Kalyani Publishers; New Delhi, India: 2010.
-
- Kumar A., Kumar P., Nadendla R. A review on: Abelmoschus esculentus (Okra) Int. Res. J. Pharm. Appl. Sci. 2013;3:129–132.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
